HAE RSI Chart
Last 7 days
-0.7%
Last 30 days
6.4%
Last 90 days
24.8%
Trailing 12 Months
11.5%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 1.2B | 1.2B | 1.2B | 1.3B |
2022 | 993.2M | 1.0B | 1.1B | 1.1B |
2021 | 870.5M | 903.4M | 933.8M | 953.2M |
2020 | 988.5M | 945.6M | 902.5M | 883.9M |
2019 | 967.6M | 976.7M | 987.7M | 999.3M |
2018 | 903.9M | 922.3M | 938.5M | 951.8M |
2017 | 886.1M | 887.1M | 892.2M | 898.4M |
2016 | 908.8M | 905.4M | 905.9M | 900.4M |
2015 | 910.4M | 899.3M | 891.4M | 893.0M |
2014 | 938.5M | 943.5M | 935.3M | 925.0M |
2013 | 892.0M | 935.1M | 952.6M | 947.4M |
2012 | 727.8M | 733.8M | 772.5M | 828.7M |
2011 | 676.7M | 684.2M | 696.8M | 711.2M |
2010 | 645.4M | 654.4M | 664.1M | 675.8M |
2009 | 597.9M | 609.8M | 621.7M | 633.5M |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
May 06, 2024 | lingamneni anila | sold | -218,975 | 95.00 | -2,305 | evp, chief technology officer |
May 02, 2024 | darecca james | sold (taxes) | -40,318 | 93.33 | -432 | evp, chief financial officer |
Apr 15, 2024 | lingamneni anila | sold (taxes) | -15,617 | 84.88 | -184 | evp, chief technology officer |
Mar 11, 2024 | simon, christopher | gifted | - | - | -38,900 | president & ceo |
Nov 01, 2023 | galvin roy | sold (taxes) | -13,822 | 86.39 | -160 | president, global plasma & bc |
Oct 20, 2023 | basil michelle l | sold (taxes) | -17,542 | 89.05 | -197 | evp and general counsel |
Oct 20, 2023 | strong stewart w | sold (taxes) | -10,686 | 89.05 | -120 | president, global hospital |
Sep 15, 2023 | miller laurie a. | sold (taxes) | -18,833 | 90.11 | -209 | svp, human resources |
Sep 12, 2023 | strong stewart w | sold | -20,668 | 90.65 | -228 | president, global hospital |
Sep 11, 2023 | lingamneni anila | sold | -207,450 | 90.00 | -2,305 | evp, chief technology officer |
Which funds bought or sold HAE recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 10, 2024 | VANGUARD GROUP INC | reduced | -0.17 | -1,631,370 | 460,662,000 | 0.01% |
May 10, 2024 | Edgestream Partners, L.P. | new | - | 1,722,960 | 1,722,960 | 0.09% |
May 10, 2024 | Covestor Ltd | added | 184 | 38,000 | 58,000 | 0.04% |
May 10, 2024 | MACKENZIE FINANCIAL CORP | unchanged | - | -506 | 270,133 | -% |
May 10, 2024 | BlackRock Inc. | reduced | -0.92 | -5,714,940 | 510,767,000 | 0.01% |
May 10, 2024 | GROUP ONE TRADING, L.P. | sold off | -100 | -2,565 | - | -% |
May 10, 2024 | Y-Intercept (Hong Kong) Ltd | sold off | -100 | -399,246 | - | -% |
May 10, 2024 | JUPITER ASSET MANAGEMENT LTD | reduced | -78.81 | -778,105 | 208,681 | -% |
May 10, 2024 | DIMENSIONAL FUND ADVISORS LP | added | 11.41 | 7,916,400 | 78,613,300 | 0.02% |
May 10, 2024 | Campbell & CO Investment Adviser LLC | reduced | -34.98 | -715,720 | 1,323,440 | 0.11% |
Unveiling Haemonetics Corp's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to Haemonetics Corp)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 182.1B | 40.3B | 32.37 | 4.52 | ||||
BDX | 67.9B | 19.7B | 50.95 | 3.44 | ||||
ALGN | 21.1B | 3.9B | 45.66 | 5.39 | ||||
BAX | 18.3B | 14.9B | 6.92 | 1.23 | ||||
MID-CAP | ||||||||
ATR | 9.9B | 3.5B | 31.58 | 2.79 | ||||
HSIC | 9.4B | 12.5B | 24.24 | 0.76 | ||||
BIO | 7.9B | 2.6B | -24.53 | 3.04 | ||||
XRAY | 5.9B | 3.9B | -62.62 | 1.49 | ||||
AXNX | 3.4B | 387.1M | -215.82 | 8.88 | ||||
PDCO | 2.4B | 6.6B | 12.18 | 0.36 | ||||
SMALL-CAP | ||||||||
AHCO | 1.2B | 3.2B | -1.76 | 0.38 | ||||
ANIK | 374.6M | 169.3M | -4.88 | 2.21 | ||||
ANGO | 245.1M | 324.0M | -1.27 | 0.76 | ||||
APYX | 57.5M | 50.5M | -2.52 | 1.14 | ||||
AEMD | 3.1M | 3.7M | -0.25 | 0.82 |
Haemonetics Corp News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Revenue | 5.7% | 336 | 318 | 311 | 304 | 305 | 297 | 261 | 265 | 260 | 240 | 229 | 225 | 240 | 209 | 196 | 238 | 259 | 253 | 238 | 249 | 247 |
Gross Profit | 4.3% | 178 | 171 | 167 | 156 | 159 | 158 | 142 | 136 | 139 | 123 | 108 | 82.00 | 120 | 106 | 90.00 | 114 | 128 | 127 | 116 | 111 | 111 |
Operating Expenses | -2.5% | 132 | 135 | 114 | 121 | 115 | 111 | 111 | 117 | 103 | 98.00 | 107 | 103 | 80.00 | 47.00 | 78.00 | 88.00 | 87.00 | 77.00 | 129 | 87.00 | 83.00 |
S&GA Expenses | 6.5% | 112 | 105 | 93.00 | 98.00 | 95.00 | 92.00 | 92.00 | 92.00 | 81.00 | 76.00 | 91.00 | 84.00 | 66.00 | 64.00 | 62.00 | 53.00 | 78.00 | 78.00 | 73.00 | 54.00 | 74.00 |
R&D Expenses | 4.7% | 13.00 | 13.00 | 13.00 | 16.00 | 13.00 | 11.00 | 11.00 | 13.00 | 10.00 | 11.00 | 13.00 | 11.00 | 8.00 | 7.00 | 8.00 | 9.00 | 7.00 | 7.00 | 7.00 | 9.00 | 9.00 |
EBITDA Margin | -1.8% | 0.20* | 0.20* | 0.23* | 0.21* | 0.20* | 0.20* | 0.19* | 0.17* | 0.13* | 0.13* | 0.17* | 0.19* | - | - | - | - | - | - | - | - | - |
Interest Expenses | - | - | - | - | - | - | - | - | - | - | - | 1.00 | 2.00 | 1.00 | 2.00 | 3.00 | 2.00 | 4.00 | 3.00 | 4.00 | 4.00 | 4.00 |
Income Taxes | 61.4% | 13.00 | 8.00 | 11.00 | 3.00 | 9.00 | 8.00 | 6.00 | 6.00 | 8.00 | 5.00 | 1.00 | -16.38 | 6.00 | 7.00 | -2.50 | 4.00 | 8.00 | 8.00 | -9.25 | 1.00 | 7.00 |
Earnings Before Taxes | 34.1% | 44.00 | 33.00 | 52.00 | 33.00 | 42.00 | 41.00 | 25.00 | 15.00 | 31.00 | 20.00 | -3.01 | -27.40 | 37.00 | 55.00 | 8.00 | 22.00 | 38.00 | 45.00 | -17.73 | 22.00 | 25.00 |
EBT Margin | -1.3% | 0.13* | 0.13* | 0.14* | 0.12* | 0.11* | 0.10* | 0.09* | 0.06* | 0.02* | 0.03* | 0.07* | 0.08* | - | - | - | - | - | - | - | - | - |
Net Income | 25.4% | 31.00 | 25.00 | 41.00 | 29.00 | 33.00 | 33.00 | 20.00 | 10.00 | 23.00 | 15.00 | -4.45 | -11.04 | 32.00 | 48.00 | 11.00 | 18.00 | 30.00 | 37.00 | -8.48 | 21.00 | -8.48 |
Net Income Margin | -3.7% | 0.10* | 0.10* | 0.11* | 0.10* | 0.08* | 0.08* | 0.07* | 0.04* | 0.02* | 0.03* | 0.07* | 0.09* | - | - | - | - | - | - | - | - | - |
Free Cashflow | -130.7% | -22.83 | 74.00 | 9.00 | 68.00 | 48.00 | 51.00 | -3.47 | 33.00 | 36.00 | 23.00 | -15.60 | -10.09 | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Assets | 9.4% | 2,200 | 2,011 | 1,962 | 1,935 | 1,878 | 1,865 | 1,821 | 1,860 | 1,831 | 1,801 | 1,794 | 1,820 | 1,318 | 1,418 | 1,433 | 1,267 | 1,238 | 1,191 | 1,260 | 1,275 | 1,228 |
Current Assets | -11.6% | 765 | 866 | 802 | 770 | 706 | 716 | 688 | 756 | 729 | 699 | 684 | 694 | 668 | 760 | 759 | 604 | 583 | 568 | 615 | 576 | 516 |
Cash Equivalents | -44.7% | 194 | 351 | 286 | 284 | 224 | 241 | 215 | 259 | 237 | 192 | 173 | 192 | 189 | 279 | 276 | 137 | 126 | 112 | 190 | 169 | 155 |
Inventory | 6.4% | 304 | 286 | 289 | 259 | 256 | 255 | 278 | 293 | 306 | 323 | 327 | 323 | 300 | 305 | 295 | 270 | 254 | 245 | 222 | 194 | 169 |
Net PPE | 3.5% | 319 | 308 | 304 | 311 | 313 | 308 | 288 | 258 | 239 | 224 | 215 | 218 | 240 | 240 | 243 | 253 | 268 | 264 | 277 | 344 | 351 |
Goodwill | 19.3% | 555 | 465 | 466 | 466 | 466 | 465 | 466 | 467 | 468 | 469 | 466 | 466 | 216 | 215 | 217 | 8.00 | 211 | 211 | 211 | 211 | 211 |
Current Liabilities | -0.9% | 262 | 264 | 237 | 252 | 227 | 262 | 180 | 442 | 355 | 288 | 228 | 253 | 194 | 339 | 408 | 275 | 257 | 240 | 294 | 236 | 211 |
Long Term Debt | 14.5% | 857 | 749 | 751 | 754 | 757 | 760 | 763 | 559 | 633 | 698 | 767 | 691 | 293 | 297 | 297 | 306 | 310 | 314 | 318 | 322 | 327 |
LT Debt, Current | 1.3% | 14.00 | 14.00 | 14.00 | 12.00 | 10.00 | 58.00 | 7.00 | 214 | 144 | 83.00 | 17.00 | 17.00 | 17.00 | 167 | 231 | 77.00 | 62.00 | 57.00 | 118 | 28.00 | 17.00 |
LT Debt, Non Current | 14.5% | 857 | 749 | 751 | 754 | 757 | 760 | 763 | 559 | 633 | 698 | 767 | 691 | 293 | 297 | 297 | 306 | 310 | 314 | 318 | 322 | 327 |
Shareholder's Equity | 5.6% | 943 | 894 | 865 | 818 | 776 | 729 | 770 | 749 | 731 | 699 | 677 | 732 | 719 | 668 | 609 | 587 | 575 | 584 | 591 | 668 | 591 |
Retained Earnings | 10.1% | 340 | 309 | 284 | 253 | 224 | 204 | 222 | 202 | 193 | 169 | 155 | 158 | 169 | 137 | 89.00 | 79.00 | 70.00 | 86.00 | 99.00 | 161 | 141 |
Additional Paid-In Capital | 1.6% | 627 | 617 | 610 | 595 | 587 | 564 | 580 | 572 | 567 | 558 | 551 | 603 | 579 | 569 | 563 | 553 | 538 | 534 | 525 | 536 | 531 |
Shares Outstanding | 0.1% | 51.00 | 51.00 | 51.00 | 50.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | 51.00 | - | - | - | - | - | - | - | - | - |
Float | - | - | - | - | - | - | 3,725 | - | - | - | 3,658 | - | - | - | 4,380 | - | - | - | 6,235 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 |
Cashflow From Operations | -100.5% | -540 | 99,124 | 19,086 | 79,611 | 64,415 | 87,039 | 41,993 | 68,050 | 62,433 | 43,460 | -1,680 | 1,547 | 66,291 | 29,155 | 11,812 | 46,406 | 79,282 | 29,901 | 2,628 | 20,638 | 58,164 |
Share Based Compensation | 7.6% | 7,217 | 6,706 | 6,989 | 7,058 | 7,491 | 5,735 | 5,299 | 5,097 | 6,455 | 5,979 | 6,828 | 7,110 | 6,287 | 5,952 | 6,167 | 5,399 | 5,325 | 5,000 | 4,730 | 4,445 | 4,782 |
Cashflow From Investing | -970.0% | -268,937 | -25,135 | -15,261 | -18,006 | -36,500 | -31,068 | -58,214 | -34,512 | -15,462 | -20,520 | -15,851 | -429,100 | -9,581 | 37,135 | -23,896 | -45,135 | -19,866 | 5,964 | 1,861 | -13,217 | -27,585 |
Cashflow From Financing | 1625.8% | 109,429 | -7,172 | -598 | -1,603 | -49,680 | -25,686 | -23,395 | -8,765 | -2,035 | -3,315 | -1,634 | 432,759 | -149,940 | -64,318 | 148,951 | 11,372 | -46,153 | -112,517 | 16,090 | 6,995 | -76,207 |
Buy Backs | - | - | - | - | - | - | 75,000 | - | - | - | - | - | - | - | - | - | - | 50,000 | 50,000 | 75,000 | 2,500 | 75,000 |
CONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Dec. 30, 2023 | Dec. 31, 2022 | Dec. 30, 2023 | Dec. 31, 2022 | |
Income Statement [Abstract] | ||||
Net revenues | $ 336,250 | $ 305,301 | $ 965,765 | $ 864,244 |
Cost of goods sold | 158,383 | 146,594 | 450,123 | 405,396 |
Gross profit | 177,867 | 158,707 | 515,642 | 458,848 |
Operating expenses: | ||||
Research and development | 13,265 | 12,689 | 38,578 | 34,487 |
Selling, general and administrative | 111,713 | 94,661 | 310,099 | 278,917 |
Amortization of acquired intangible assets | 6,911 | 8,078 | 21,606 | 24,666 |
Impairment of assets | 0 | 0 | 10,419 | 0 |
Total operating expenses | 131,889 | 115,428 | 380,702 | 338,070 |
Operating income | 45,978 | 43,279 | 134,940 | 120,778 |
Interest and other expense, net | (1,949) | (1,055) | (6,489) | (12,001) |
Income before provision for income taxes | 44,029 | 42,224 | 128,451 | 108,777 |
Provision for income taxes | 12,788 | 9,280 | 31,260 | 22,759 |
Net income | $ 31,241 | $ 32,944 | $ 97,191 | $ 86,018 |
Basic income (loss) per share (in dollars per share) | $ 0.62 | $ 0.65 | $ 1.92 | $ 1.69 |
Diluted income (loss) per share (in dollars per share) | $ 0.61 | $ 0.64 | $ 1.89 | $ 1.67 |
Weighted average shares outstanding | ||||
Basic (in shares) | 50,768 | 50,509 | 50,679 | 50,896 |
Diluted (in shares) | 51,445 | 51,219 | 51,394 | 51,487 |
Comprehensive income | $ 39,564 | $ 37,400 | $ 103,190 | $ 76,173 |
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands | Dec. 30, 2023 | Apr. 01, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 193,978 | $ 284,466 |
Accounts receivable, less allowance for credit losses of $5,725 at December 30, 2023 and $4,932 at April 1, 2023 | 211,611 | 179,142 |
Inventories, net | 304,024 | 259,379 |
Prepaid expenses and other current assets | 55,369 | 46,735 |
Total current assets | 764,982 | 769,722 |
Property, plant and equipment, net | 318,665 | 310,885 |
Intangible assets, less accumulated amortization of $442,810 at December 30, 2023 and $417,422 at April 1, 2023 | 429,270 | 275,771 |
Goodwill | 554,999 | 466,231 |
Deferred tax asset | 5,070 | 5,241 |
Other long-term assets | 127,442 | 106,975 |
Total assets | 2,200,428 | 1,934,825 |
Current liabilities: | ||
Notes payable and current maturities of long-term debt | 13,736 | 11,784 |
Accounts payable | 56,845 | 63,929 |
Accrued payroll and related costs | 58,762 | 64,475 |
Other current liabilities | 132,412 | 111,628 |
Total current liabilities | 261,755 | 251,816 |
Long-term debt | 856,849 | 754,102 |
Deferred tax liability | 62,246 | 36,195 |
Other long-term liabilities | 76,259 | 74,715 |
Stockholders’ equity: | ||
Common stock, $0.01 par value; Authorized — 150,000,000 shares; Issued and outstanding — 50,785,040 shares at December 30, 2023 and 50,448,519 shares at April 1, 2023 | 508 | 504 |
Additional paid-in capital | 627,094 | 594,706 |
Retained earnings | 340,099 | 253,168 |
Accumulated other comprehensive loss | (24,382) | (30,381) |
Stockholders’ equity: | 943,319 | 817,997 |
Total liabilities and stockholders’ equity | $ 2,200,428 | $ 1,934,825 |